Cancer statistics, 2019
Статистика онкологических заболеваний, 2019 год
2019-01-01
SCID: 54.1/pn2eccgy
Discuss with AI
cancer incidencecancer mortalitycancer statisticscancer survivalsocioeconomic inequalities
Figures from the paper
Abstract (AI)
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data, available through 2015, were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data, available through 2016, were collected by the National Center for Health Statistics. In 2019, 1,762,450 new cancer cases and 606,880 cancer deaths are projected to occur in the United States. Over the past decade of data, the cancer incidence rate (2006-2015) was stable in women and declined by approximately 2% per year in men, whereas the cancer death rate (2007-2016) declined annually by 1.4% and 1.8%, respectively. The overall cancer death rate dropped continuously from 1991 to 2016 by a total of 27%, translating into approximately 2,629,200 fewer cancer deaths than would have been expected if death rates had remained at their peak. Although the racial gap in cancer mortality is slowly narrowing, socioeconomic inequalities are widening, with the most notable gaps for the most preventable cancers. For example, compared with the most affluent counties, mortality rates in the poorest counties were 2-fold higher for cervical cancer and 40% higher for male lung and liver cancers during 2012-2016. Some states are home to both the wealthiest and the poorest counties, suggesting the opportunity for more equitable dissemination of effective cancer prevention, early detection, and treatment strategies. A broader application of existing cancer control knowledge with an emphasis on disadvantaged groups would undoubtedly accelerate progress against cancer.
Key Findings
1
Cancer incidence was stable among women and declined approximately 2% annually among men from 2006 to 2015.
2
Cancer mortality declined annually by 1.4% in women and 1.8% in men from 2007 to 2016.
3
Socioeconomic disparities in cancer mortality are widening: during 2012-2016, the poorest counties had twice the cervical cancer mortality and 40% higher male lung and liver cancer mortality than the most affluent counties.
4
The United States projected 1,762,450 new cancer cases and 606,880 cancer deaths for 2019.
5
The overall cancer death rate fell 27% from 1991 to 2016, corresponding to approximately 2,629,200 fewer deaths than expected at peak rates.
Research Object
Cancer incidence, mortality, and survival in the United States
Research Subject
Temporal trends and socioeconomic and racial disparities in cancer incidence and mortality, including projected 2019 cases and deaths
Publication Details
Publication Date
2019-01-01
Journal
Publisher
ISSN
Cited by
21023
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
Cited by16
Cancer Statistics, 20212021
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 20152016
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 20172019
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013–20172020
Comprehensive review of targeted therapy for colorectal cancer2020
Cancer Progress and Priorities: Lung Cancer2019
Cancer health disparities in racial/ethnic minorities in the United States2020
Electrospinning for drug delivery applications: A review2021
The Application of Deep Learning in Cancer Prognosis Prediction2020
Boron neutron capture therapy: Current status and future perspectives2020
N1-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism2021
Breast histopathological image analysis using image processing techniques for diagnostic purposes: A methodological review2021
Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient’s Stratification2022
Gut Microbiota Disruption in Hematologic Cancer Therapy: Molecular Insights and Implications for Treatment Efficacy2024
In-house homologous recombination deficiency testing in ovarian cancer: a multi-institutional Italian pilot study2023
Synthesis, Characterization, and In Vivo Anti-Cancer Activity of New Metal Complexes Derived from Isatin-N(4)antipyrinethiosemicarbazone Ligand Against Ehrlich Ascites Carcinoma Cells2019